Welcome to our new website! If this is the first time you are logging in on the new site, you will need to reset your password. Please contact us at raps@raps.org if you need assistance.
Your membership opens the door to free learning resources on demand. Check out the Member Knowledge Center for free webcasts, publications and online courses.
Our new book is a comprehensive look at a vital part of medicines development and regulatory affairs. Grab your copy today!
Hear from leaders around the globe as they share insights about their experiences and lessons learned throughout their certification journey.
| 14 November 2013 | By Louise Zornoza,
Australia's Therapeutic Goods Administration (TGA) and New Zealand's Medicines and Medical Devices Safety Authority (Medsafe) announced on 13 November 2013 the next stage of their joint efforts toward regulatory harmonization and the launch of a joint regulatory agency, the Australia New Zealand Therapeutic Products Agency (ANZTPA)..
This new phase of joint work will cover the next two and a half years and targets 14 activities across the following six regulatory areas: medicines (prescription and non-prescription), medicines ingredients, safety, medical devices, and biological and blood products.
The Medsafe/TGA ANZTPA Implementation Steering Committee will oversee the multiple harmonization activities to link with the ongoing Australian Blueprint reforms program and the needed timing for ANZTPA Rules and Orders development.
ANZTPA Statement
Read all Breaking News from RegLink
Tags: Regulatory Harmonization, New Zealand, harmonization, australia